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Abstract
 
We studied the role of CD43 (leukosialin/sialophorin), the negatively charged sialoglycopro-
tein of leukocytes, in the binding of mycobacteria to host cells. CD43-transfected HeLa cells
bound 
 
Mycobacterium avium
 
, but not 
 
Salmonella typhimurium
 
 or 
 
Shigella flexneri
 
. Quantitative bac-
teriology showed that macrophages (M
 
f
 
) from wild-type mice (CD43
 
1
 
/
 
1
 
) bound 
 
M
 
.
 
 avium
 
,
 
Mycobacterium bovis
 
 (bacillus Calmette-Guérin), and 
 
Mycobacterium tuberculosis
 
 (strain H37Rv),
whereas M
 
f
 
 from CD43 knockout mice (CD43
 
2
 
/
 
2
 
) did not. Fluorescence microscopy dem-
onstrated that the associated 
 
M
 
. 
 
avium
 
 had been ingested by the CD43
 
1
 
/
 
1
 
 M
 
f
 
. The inability of
CD43
 
2
 
/
 
2
 
 M
 
f
 
 to bind 
 
M
 
.
 
 avium
 
 could be restored by addition of galactoglycoprotein (Galgp),
the extracellular mucin portion of CD43. The effect of Galgp is not due to opsonization of the
bacteria, but required its interaction with the M
 
f
 
; other mucins had no effect. CD43 expres-
sion by the M
 
f
 
 was also required for optimal induction by 
 
M
 
.
 
 avium 
 
of tumor necrosis factor
(TNF)-
 
a
 
 production, which likewise could be reconstituted by Galgp. In contrast, interleukin
(IL)-10 production by 
 
M
 
.
 
 avium–
 
infected M
 
f
 
 was CD43 independent, demonstrating discor-
dant regulation of TNF-
 
a
 
 and IL-10. These findings describe a novel role of CD43 in promot-
ing stable interaction of mycobacteria with receptors on the M
 
f
 
 enabling the cells to respond
specifically with TNF-
 
a
 
 production.
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Introduction
 
Mycobacteria are among the most important infectious
agents in the world. 
 
Mycobacterium tuberculosis
 
, which is
spread by airborne transmission, causes more deaths glo-
bally than any other infectious agent. Estimates indicate 90
million people infected with 
 
M
 
.
 
 tuberculosis
 
 during the cur-
rent decade, 30 million of whom will die as a result of in-
fection (1). In the United States, 
 
Mycobacterium avium 
 
com-
plex has emerged as the most prevalent opportunistic
infection among patients with advanced HIV-1 infection.
 
M
 
.
 
 avium
 
 infections in patients with AIDS and other im-
munodeficiencies typically manifest with widespread vis-
ceral organ involvement and high-grade bacteremia; the
patients suffer considerable morbidity and shortened life
span (2–5).
 
Macrophages (M
 
f
 
),
 
1 
 
the predominant host cells, are the
first line defense against spread of mycobacterial infection.
In the successful process, M
 
f
 
 eliminate mycobacterial in-
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f
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fection by a complex network of events involving TNF-
 
a
 
production (6) and leading to apoptosis and elimination of
the host M
 
f
 
 containing endocytosed microorganisms (7, 8).
Pathogenic mycobacteria have evolved mechanisms to sur-
vive and replicate within endosomes of M
 
f
 
 (9) after enter-
ing the cells by one of several M
 
f
 
 receptor pathways. These
include complement receptors CR1, CR3, and CR4, man-
nose receptor, CD14, Fc receptors, scavenger receptors, and
one or more receptors for pulmonary surfactant protein A
(SP-A) (10, 11). To some extent, the outcome of mycobac-
terial infection is influenced by the receptor, in that uptake
via Fc receptors, but not complement receptors, induces re-
active oxygen metabolites, a process believed to decrease
survival of endocytosed mycobacteria (12).
This study aims to understand the role of nonreceptor
surface molecules in regulating binding and uptake of my-
cobacteria by M
 
f
 
. CD43, a cell surface mucin on mac-
rophages, was considered as a candidate regulatory mole-
cule because of its known ability to interfere with adhesion
processes. For example, CD43-transfected HeLa cells, un-
like wild-type HeLa cells, display decreased intracellular
adhesion molecule (ICAM)-mediated adhesion (13), and
targeted disruption of the CD43 gene in mice increased ad-
hesiveness of splenic T cells (14). Therefore, we used
CD43-transfected and wild-type HeLa cells as well as M
 
f
 
from CD43 knockout and wild-type mice to determine
whether the presence of CD43 diminishes binding of my-
cobacteria to M
 
f
 
 and, by doing so, diminishes or abrogates
important downstream events such as cytokine production.
 
Materials and Methods
 
Animals.
 
CD43 knockout mice were generated by homolo-
gous recombination via embryonic stem cell chimeras (14). The
CD43
 
2
 
/
 
2
 
 mice and control wild-type mice (in C57 
 
3 
 
SVJ 129
background) were maintained under specific pathogen-free con-
ditions at the Tufts University School of Medicine. For all exper-
iments, 6–8-wk-old mice matched for sex were used. In select
experiments, gene status was verified by flow cytometric analysis
of cells stained with PE-conjugated S7 rat anti–mouse CD43
mAb (BD PharMingen).
 
Microorganisms. Shigella flexneri
 
 and 
 
Salmonella typhimurium
 
were provided by Dr. J. Cohen, Imperial College of Science,
Technology and Medicine (London, UK). BCG (
 
M
 
.
 
 bovis 
 
strain
bacillus Calmette-Guérin
 
) 
 
was obtained from the Trudeau Insti-
tute, Saranac Lake, NY. The 
 
M
 
.
 
 tuberculosis
 
 strain H37Rv was a
gift of Dr. Hardy Kornfeld, Boston University School of Medi-
cine. 
 
M
 
.
 
 avium
 
 serovar 4, isolated from an AIDS patient and typed
by the Mycobacterial Culture Collection (National Jewish Hospi-
tal, Denver, CO), was grown to log phase in Middlebrook 7H9
broth with 5 mg/ml albumin, 1 mg/ml dextrose, and 3 
 
m
 
g/ml
catalase (OADC; Difco). The mycobacteria were harvested by
centrifugation (2,000 
 
g
 
), washed twice in HBSS, suspended in
Middlebrook 7H9 broth, sonicated for 10 s at 500 W, and stored
in aliquots at 
 
2
 
70
 
8
 
C. 
 
M
 
.
 
 avium
 
, BCG, and 
 
M
 
.
 
 tuberculosis
 
 were
thawed as needed, sonicated for 20 s to disperse the bacteria, and
quantified by plate counting. 10-fold dilutions (5 replicates per
dilution) were plated on Middlebrook 7H11 agar with albumin-
dextrose-catalase enrichment. The plates were incubated at 37
 
8
 
C
in 90% humidity for 10 d to 4 wk, and colonies were counted.
 
M
 
. 
 
avium
 
 colonies were exclusively of the smooth, transparent
morphotype (15) and appeared homogeneously dispersed.
 
HeLa Cell Lines.
 
The generation of HeLa cell CD43 trans-
fectants was described previously (13). Wild-type HeLa cells and
HeLa cells transfected with vector (pSV2Neo) were used as con-
trols. The cells in RPMI 1640 with 10% heat-treated (56
 
8
 
C for
30 min) FCS and 25 mM Hepes were propagated by plating 2 
 
3
 
10
 
6 
 
cells/ml in 24-well culture plates (Costar) and passaging by
EDTA treatment. Immediately before infection, confluent HeLa
cells were washed three times with HBSS, and fresh medium was
added.
Live 
 
M
 
.
 
 avium
 
, 
 
S. flexneri
 
,
 
 
 
and
 
 S. typhimurium
 
 were stained
with carboxyfluorescein diacetate (CFDA; Molecular Probes).
The bacteria at 10
 
7
 
/ml were incubated with 4 
 
m
 
M CFDA in
DMEM at 37
 
8
 
C for 30 min. After extensive washing, the CFDA-
stained microorganisms were used to challenge confluent cultures
of CD43-transfected, wild-type, and vector-transfected HeLa
cells by coculture at 1, 5, or 10 microorganisms/cell for 2–4 h.
The cells were washed three times in HBSS and analyzed by flu-
orescence microscopy.
 
Murine Spleen M
 
f
 
.
 
Murine spleens were removed sterilely
and teased, and the released cells were washed three times in
HBSS and suspended in RPMI 1640 with 10% heat-treated
(56
 
8
 
C for 30 min) FCS, 25 mM Hepes, and 2 
 
3
 
 10
 
2
 
5
 
 M 2-ME
(Sigma-Aldrich). All media tested negative for LPS (
 
,
 
0.05 ng/
ml) in the Limulus amebocyte lysate assay (BioWhittaker). Spleen
cells were plated at 2 
 
3
 
 10
 
6
 
 cells/well in 24-well plates (Costar)
for 4–6 d in 5% CO
 
2
 
 at 378C. Immediately before infection,
nonadherent cells were discarded, and the Mf populations,
which were 97–99% pure by esterase stain, were washed four
times in HBSS, and fresh medium was added.
Triplicate wells of adherent Mf (z1.0 3 105 cells/well) were
inoculated with M. avium, BCG, or M. tuberculosis strain H37Rv
at 2, 10, or 20 microorganisms/cell and cultured for 1–4 h for
mycobacteria binding assays or 4–48 h for cytokine measure-
ments. To quantify bound mycobacteria, the adherent Mf were
washed four times with HBSS, lysed by addition of SDS (500 ml
of 0.2%), and the effect of SDS was terminated with FCS (500 ml
50%). Cell lysates (100 ml) were cultured at 378C in 5-ml vials
containing culture broth and [14C]palmitic acid (Bactec vials;
Becton Dickinson). Accumulated 14CO2 was quantified at 24-h
intervals using the Bactec model 460TB system (Becton Dickin-
son). Plots of accumulated 14CO2 versus time of culture yielded
T-100 values, defined as time needed to reach 14CO2 accumula-
tion value of 100 on a scale of 0–999 (16). Linear correlation was
found between T-100 and the log of bacterial number over the
range 101 to 107 organisms, and assay results, expressed as number
of mycobacteria associated with Mf, were determined from a
calibration plot. Calibration was provided by periodic parallel as-
say of mycobacteria that had been quantified by plate counting.
Light Microscopy. Monolayers of adherent Mf were prepared
by plating 2 3 106 murine spleen cells on 13-mm-diameter plas-
tic coverslips (Thermanox™, no. 174950; Nunc); these were in-
cubated with M. avium, harvested and washed as described above,
and dried. The coverslips were stained with TB carbolfuchsein
KF and counterstained with TB brilliant green K following the
manufacturer’s instructions (Kinyoun acid-fast staining procedure
for mycobacteria; Difco). Mf containing .10 detectable bacteria
were scored as positive. Quantitation is based on visual scoring of
3–5 fields with 30–80 cells each.
Fluorescence Microscopy. Monolayers of adherent Mf on plas-
tic coverslips as described above were incubated with M. avium,
harvested, washed, and fixed with 4% paraformaldehyde in PBS.185 Fratazzi et al.
The mycobacteria in the fixed monolayers were stained with the
rhodamine-auramine TB Fluorescent stain kit (no. 4312521;
Becton Dickinson) according to the manufacturer’s directions.
The stained cells were examined by phase–contrast and fluores-
cent microscopy with a Nikon microscope.
Galactoglycoprotein and Other Mucins. Galactoglycoprotein
(Galgp; provided by Dr. Karl Schmid, Department of Biochemis-
try, Boston University School of Medicine, and Dr. H. Gerhard
Schwick, Behringwerke AG, Marburg/Lahn, Germany), was pu-
rified from pooled normal human plasma by anion exchange
chromatography of the supernatant of Cohn fraction V followed
by gel filtration (17) with the additional step of solid-phase im-
munoabsorption using antiserum raised in a rabbit that had been
immunized with Galgp but that produced antibodies only against
the trace contaminants (18). Galgp appeared as a single z120-kD
band on SDS gels stained with Alcian blue, a glycoprotein stain
(19), and no component was detected when overloaded gels (50
mg samples) were stained with the protein stain Coomassie blue
(data not shown).
Antifreeze fish glycoprotein (AFGP) (20) isolated from North-
ern cod (mol wt of z3,000) was provided by A/F Protein, Inc.
(Waltham, MA). Purified porcine submaxillary gland mucin
(PSM) was reduced, carboxymethylated, and treated with trypsin
to generate a monomeric mucin species (PSM-RT) (21). The
mucins were added to Mf cultures at the same time as M. avium,
unless otherwise noted.
Measurement of TNF-a and IL-10. Murine spleen Mf were
isolated, cultured in 24-well plates, and inoculated with M. avium
as described above. At 4–48 h after infection, supernatants were
harvested and the concentrations of TNF-a and IL-10 were de-
termined by ELISA using matched antibody pairs and cytokine
standards (Endogen).
Phagocytosis. Monolayers of murine spleen Mf were pre-
pared by plating 2 3 106 murine spleen cells on plastic coverslips
as described for microscopy experiments. 4–6 d later, the adher-
ent monolayers were washed and polystyrene (latex) fluorescent
microspheres of 1-mm diameter (Fluoresbrite YG Microspheres;
Polysciences, Inc.) were added to triplicate wells at a ratio of 200
beads/Mf and incubated for 30 min. The coverslips were washed
five times in HBSS at 378C and air-dried. The Mf were exam-
ined in a Nikon microscope; cells with at least two phagocytized
beads were scored as positive.
Statistical Analysis. The results are expressed as the mean 6
SEM. Statistical differences were determined using SigmaStat Sta-
tistical Software (Jandel Scientific), using the t test for normally
distributed data with equal variances and the Mann-Whitney rank
sum test for data populations with nonnormal distributions and/
or unequal variances.
Results
CD43 Is Required for Optimal Binding of Mycobacteria to Mf.
As our initial approach, we incubated CD43-transfected
HeLa cells and control HeLa cells with M. avium, S. typhi-
murium, and S. flexneri. After 4 h exposure to the patho-
gen, we quantified the cells that had bound bacteria.
Contrary to expectations, M. avium were found to be stably
associated with the CD43-transfected HeLa cells (Fig. 1,
left) and were not associated with control HeLa cells, both
wild-type (data not shown) and vector-transfected cells
(Fig. 1, right). The binding of M. avium to CD43-express-
ing HeLa cells appeared to be specific, since neither of the
other tested bacterial species, S. typhimurium and S. flexneri,
bound to CD43-transfected (or control) HeLa cells (Fig. 1).
The surprising finding that M. avium bind to CD431
HeLa cells prompted us to examine the role of CD43 in
Figure 1. Specific association of M. avium with CD43-transfected
HeLa cells. HeLa cells transfected with CD43 (HeLa-CD43) and vector-
transfected cells (HeLa) were incubated as indicated with stained live M.
avium, S. typhimurium, and S. flexneri at 10 organisms/cell for 4 h. Cells
were washed, and the infected cells were counted using fluorescence mi-
croscopy (see Materials and Methods). Shown is a representative experi-
ment. The number of CD43-transfected HeLa cells that scored positive
for M. avium binding was significantly different than the number of vec-
tor-transfected cells (n 5 3, P , 0.0001).
Figure 2. Binding of M. avium and M. tuberculosis to murine CD431/1
and CD432/2 Mf examined by quantitative bacteriology. (A) M. avium
serovar 4 were incubated with adherent splenic Mf (z1 3 105) at a bac-
teria/cell ratio of 2:1 for the indicated time; the Mf were extensively
washed, and the adherent bacteria were quantified. (B) M. tuberculosis
strain H37Rv were similarly analyzed. Shown are mean values 6 SEM
for three mice of each group. The number of M. avium and M. tuberculosis
associated with CD432/2 and CD431/1 Mf are significantly different at
all time points (P , 0.0001). Although the absolute numbers of bound
mycobacteria varied, similar differences between CD431/1 and CD432/2
Mf were observed in two additional independent experiments.186 CD43 Is Required for Mycobacterial Binding
binding of mycobacteria by Mf, their normal host cell.
Monolayers of splenic Mf were prepared from wild-type
(CD431/1) and CD43 gene–deleted (CD432/2) mice.
When these were challenged with M. avium, quantitative
bacteriology showed that the CD431/1 Mf bound signifi-
cant numbers of M. avium (Fig. 2 A). In contrast, CD432/2
Mf failed to bind M. avium or bound minimal numbers of
the bacteria. The binding of M. avium to CD431/1 Mf
was dependent on bacterial dose (shown below) and time
of coincubation (Fig. 2 A). An exposure time of 4 h was
chosen for further experiments because, at this time, bind-
ing of the M. avium to the Mf was substantial and bacterial
growth was not yet observed.
To examine whether other mycobacterial species are also
dependent on CD43 for uptake, splenic mouse Mf were
challenged with M. tuberculosis H37Rv, a virulent strain.
Whereas substantial binding was seen for CD431/1 Mf,
CD432/2 Mf failed to bind M. tuberculosis (Fig. 2 B). Sim-
ilar results, i.e., binding to CD431/1 Mf and minimal or
absent binding to CD432/2 Mf, were obtained also for
BCG (data not shown). Collectively, these findings
strongly indicate a positive role for CD43 in mycobacterial
binding.
In an independent approach, Mf incubated with M.
avium were evaluated by light microscopy after acid-fast
staining of the mycobacteria. On infection with M. avium
at a 20:1 ratio, 57 6 6% of CD431/1 Mf had .10 bacteria
detectable by staining compared with 8 6 3% of CD432/2
Mf (n 5 4).
In other experiments, Mf incubated with M. avium
were examined by fluorescence microscopy after staining
of the mycobacteria with rhodamine-auramine. When in-
cubated at a 20:1 ratio, fluorescent micrographs showed
multiple mycobacteria associated with all or most of the
CD431/1 Mf (Fig. 3 A, left) and negligible association of
mycobacteria with CD432/2 Mf (right). Higher magnifi-
cation micrographs showed that the mycobacteria associ-
ated with CD431/1 M f are localized predominantly
Figure 3. Association of M. avium with CD431/1 and
CD432/2 Mf examined by fluorescence microscopy. M.
avium were incubated with Mf at a ratio of 20:1 for 4 h.
After washing and fixing, mycobacteria associated with the
cell monolayers were stained with auramine-rhodamine
(TB staining reagents), and the preparations were exam-
ined by microscopy. (A) Shown are fluorescent micro-
graphs (top) and phase–contrast images of the same frames
(bottom) of CD431/1 (left) and CD432/2 (right) Mf.
Note that almost all of the CD431/1 Mf have multiple as-
sociated mycobacteria; in contrast, negligible numbers of
mycobacteria are associated with CD432/2 M f. (B)
Higher magnification images. Description as in A. The ar-
rows on the phase–contrast micrographs indicate the re-
gions of the cells with positive signals in the corresponding
fluorescent micrographs. Note that mycobacteria associ-
ated with CD431/1 Mf are localized within the cells. In
contrast, in the very rare CD432/2 Mf with associated
mycobacteria, the organisms are localized to the periphery
of the cell. Bar, (B) 20 mm.187 Fratazzi et al.
within the cells (Fig. 3 B, left). In contrast, in the rare cases
where mycobacteria were found associated with CD432/2
Mf, the microorganisms were localized to the periphery of
the cells (Fig. 3 B, right).
To test whether the diminished association of mycobac-
teria with CD432/2 Mf is due to a global defect in phago-
cytosis, monolayers of wild-type and CD432/2 Mf were
incubated with nonopsonized inert latex fluorospheres (200
spheres/cell) for 30 min (22). Uptake of the latex beads ex-
amined by fluorescence microscopy showed that 76 6 5%
of CD431/1 and 73 6 5% of CD432/2 Mf contained flu-
orescent beads. The finding that CD432/2 Mf do not take
up less beads than CD431/1 Mf (n 5 3, P , 0.6) suggests
that the cells are not globally defective in phagocytosis.
Galgp Restores M. avium Binding to CD432/2 Mf. The
extracellular mucin region of CD43 was identified as a nor-
mal component of human plasma, given the name Galgp,
and isolated (17). We reasoned that if CD43 functions as a
receptor for mycobacteria, addition of soluble extracellular
CD43 to wild-type Mf might abrogate mycobacterial
binding by competing with cell surface CD43. However,
addition of Galgp to CD431/1 Mf resulted in enhanced
mycobacterial binding (not shown). More importantly, ad-
dition of 100 mg/ml Galgp to CD432/2 Mf at the time of
infection restored the time-dependent (Fig. 4 A) and bacte-
rial dose–dependent (Fig. 4 B) association of M. avium with
CD432/2 M f. Restoration of M. avium binding to
CD432/2 Mf by Galgp (100 mg/ml) was also seen when
the cells were evaluated by acid-fast staining (data not
shown). These findings suggest that Mf CD43, rather than
serving as a receptor for mycobacteria, functions by pro-
moting or stabilizing binding or uptake of mycobacteria.
The proposed collaborative role of CD43 in enabling
mycobacterial association with Mf was further tested by
preincubating M. avium with Galgp for 4 h, washing the
bacteria extensively, and adding them to CD432/2 Mf for
an additional 4-h incubation. Whereas coincubation of
Galgp,  M. avium, and Mf enhanced the binding of myco-
bacteria to Mf, no enhancement was observed when my-
cobacteria were preincubated with Galgp, washed, and
then added to the cells (Fig. 5), indicating that Galgp does
not opsonize the mycobacteria.
We next determined whether other mucins are also able
to restore the association of M. avium with CD432/2 Mf.
M. avium were added to CD432/2 Mf together with 100
mg/ml of Galgp or AFGP (20) or PSM that had been re-
duced, carboxymethylated, and trypsin-treated to generate
linear monomeric mucin molecules (PSM-RT) (21). After
4 h, association of bacteria with Mf was assessed. M. avium
binding to CD432/2 Mf was enhanced only by the pres-
ence of Galgp. AFGP and PSM-RT failed to enhance asso-
ciation of M. avium with Mf (Fig. 6).
In contrast, addition of Galgp did not enhance associa-
tion of M. avium with wild-type (CD432) HeLa cells. On
infection with a 1:1 ratio, the number of bacteria associated
per 100 cells was 5, 7, and 40, respectively, for vector-
transfected HeLa, vector-transfected HeLa with Galgp (100
mg/ml), and CD43-transfected HeLa. At an infection ratio
of 5:1, the corresponding results were 10, 10, and 70 bacte-
ria bound per 100 cells. Similar results were obtained when
M. avium–challenged HeLa cells (infection ratio of 15:1)
Figure 4. Addition of Galgp restores binding of M. avium by CD432/2
Mf. (A) M. avium were incubated for varying times with CD432/2 Mf
in the absence (s) and presence (e) of 100 mg/ml Galgp. Bacteria/cell
ratio was 2:1. The Mf were harvested and extensively washed, and ad-
herent bacteria were quantified. The binding of M. avium to CD431/1
Mf in the absence of Galgp is shown for comparison (d, dashed lines).
(B) M. avium at varying bacteria/cell ratios as indicated were incubated
with CD432/2 Mf for 4 h in the absence (s) and presence (e) of 100
mg/ml Galgp. Shown are mean values 6 SEM for three mice of each
group. The number of mycobacteria associated with CD432/2 Mf in the
presence and absence of 100 mg/ml Galgp was significantly different in all
conditions (P , 0.0001). Comparable effects of Galgp addition were ob-
served in two additional experiments. Galgp at 200 mg/ml produced sim-
ilar results (data not shown).
Figure 5. Preincubation of M. avium with Galgp does not enhance
their binding to CD432/2 Mf. M. avium were preincubated for 4 h with
100 mg/ml Galgp or without additive, as indicated, and then extensively
washed. The bacteria were used to infect CD432/2 Mf (infection ratio
of two organisms per cell). Galgp (100 mg/ml) or saline was added, as in-
dicated at the time of infection. After extensive washing, M. avium associ-
ated with Mf were quantified. Shown are mean values 6 SEM for cells
from three mice. The number of M. avium associated with Mf were sig-
nificantly different for mycobacteria preincubated with Galgp compared
with M. avium infected in the presence of Galgp (P , 0.0001). Similar ef-
fects of Galgp treatment were seen in one additional experiment.188 CD43 Is Required for Mycobacterial Binding
were evaluated by acid-fast staining and light microscopy.
70% of CD43-transfected HeLa cells, but ,10% of vector-
transfected HeLa and vector-transfected HeLa with Galgp,
scored positive for bacterial association ($5 bacteria/cell).
In the case of CD43-transfected HeLa cells, the associated
mycobacteria were clearly located outside the cell perime-
ter as anticipated for these nonphagocytic cells (23).
In Contrast to CD431/1 Mf, CD432/2 Mf Fail to Pro-
duce TNF-a in Response to M. avium and This Deficiency Is
Corrected by Galgp. Early after inoculation with mycobac-
teria, wild-type Mf respond by producing the proinflam-
matory cytokine TNF-a (24), which plays a central role in
defense against microbial organisms including mycobacte-
ria (25, 26). To investigate whether M. avium–dependent
TNF-a production is altered in CD432/2 Mf, we mea-
sured TNF-a levels produced by CD432/2 and CD43 1/1
Mf over the 4–48-h period after inoculation. M. avium in-
oculation of CD431/1 Mf resulted in the production of
1,150 6 200 ng/ml TNF-a at 8 h. In contrast, CD432/2
Mf inoculated with the same M. avium/cell ratio pro-
duced  ,200 ng/ml TNF-a (Fig. 7 A). The possibility of a
TNF-a expression defect in CD432/2 Mf was ruled out
by finding that CD432/2 and wild-type Mf produced
comparable levels of TNF-a when stimulated for 8 h with
LPS (100 ng/ml; data not shown), suggesting that the de-
fective induction of TNF-a production is M. avium spe-
cific. Importantly, the inability of CD432/2 Mf to pro-
duce TNF-a in response to M. avium was overcome by the
addition of Galgp during inoculation (Fig. 7 B), and the
extent of the restorative effect was dependent on Galgp
concentration.
Incubation of wild-type Mf with mycobacteria also in-
duces production of the immunosuppressive cytokine IL-10,
which counteracts the effects of TNF-a (27). Incubation
with M. avium of CD432/2 and CD431/1 Mf induced
comparable levels of IL-10 (Fig. 7 C), indicating that the
lesser interaction of mycobacteria with CD432/2 Mf is
sufficient to induce IL-10 production. The discordant reg-
ulation of TNF-a and IL-10 demonstrates that the failure
Figure 6. Galgp, but not other mucins, enables CD432/2 Mf to bind
M. avium. M. avium at a bacteria/cell ratio of 2:1 were incubated with
CD432/2 Mf in the absence (none) or presence of Galgp, AFGP, or
PSM reduced and trypsin-treated (PSM-RT) at 100 mg/ml. After 4 h, the
cells were washed and the mycobacteria associated with cells were quanti-
fied. Shown are mean values 6 SEM for cells from three mice. The num-
ber of M. avium associated with the CD432/2 Mf incubated with the
mycobacteria in the presence of Galgp, AFGP, or PSM were significantly
different (P , 0.0001). Similar effects of mucin treatments were seen in
one additional experiment.
Figure 7. TNF-a and IL-10 production examined in CD431/1 and
CD432/2 Mf challenged with M. avium. (A) M. avium–induced TNF-a
production is significantly impaired in CD432/2 Mf. Mf from CD431/1
(d) and CD432/2 (s) mice were inoculated with M. avium (two bacteria
per Mf), and the supernatants harvested at the indicated times were as-
sayed by ELISA. The levels of TNF-a produced by M. avium–challenged
CD431/1 and CD432/2 Mf are significantly different at 4, 8, and 12 h
(P , 0.001, 0.007, and 0.01, respectively). In the absence of mycobacterial
challenge, neither CD431/1 (3) nor CD432/2 Mf (not shown) pro-
duced TNF-a. (B) Impaired TNF-a production by M. avium–challenged
CD432/2 Mf is restored by Galgp. CD432/2 Mf were inoculated with
M. avium (two bacteria per Mf) in the absence (s) and presence of 100
(e) and 200 (h) mg/ml Galgp. Galgp was tested also at 50 mg/ml, and
the resulting TNF-a levels were indistinguishable from levels produced
in the absence of added Galgp (s). Note that 200 mg Galgp increases
TNF-a to levels of CD431/1 cells at 8 and 12 h (compare with A). The
levels of TNF-a are significantly different for M. avium–challenged
CD432/2 Mf in the absence and presence of 100 and 200 mg/ml Galgp
at 8 and 12 h (P , 0.02). Note also that Mf cultured with Galgp (200
mg/ml) in the absence of mycobacterial challenge (3) did not produce
TNF-a. (C) M. avium–dependent IL-10 production is not impaired in
CD432/2 Mf. The Mf supernatants from A were assayed for IL-10 by
ELISA. The levels of IL-10 produced by CD431/1 (d) and CD432/2 (s)
Mf after inoculation with M. avium are not significantly different at any
time point (P values range from 0.06 to 0.85). Neither CD431/1 (3) nor
CD432/2 Mf (not shown) produced IL-10 in the absence of mycobacte-
rial challenge. Values are mean 6 SEM of replicate assays of fractions
from three mice of each group.189 Fratazzi et al.
to produce TNF-a in response to mycobacterial challenge
is a specific defect of CD432/2 macrophages.
Discussion
Mycobacterial diseases, some of which are spread by air-
borne transmission, are a serious global public health prob-
lem (3). In this communication, we provide the first evi-
dence identifying a new component of apparent importance
for the uptake of mycobacteria by their primary host cell, the
Mf. This component, CD43, is the predominant sialoglyco-
protein on leukocytes. We show that the presence of CD43
is obligatory for firm association of mycobacteria with Mf.
Mf from wild-type mice and CD43-transfected HeLa cells
bound high numbers of M. avium. In contrast, negligible
numbers of M. avium associated with untransfected HeLa
cells and with Mf from CD43 gene–deleted mice. The role
of CD43 in the binding of mycobacteria is specific because
other bacteria, S. typhimurium and S. flexneri, did not bind to
CD43 1 HeLa cells. Also, Mf from CD431/1 mice bound
two other species of mycobacteria, M. tuberculosis and M. bo-
vis, and these also failed to bind to CD432/2 Mf. Fluores-
cence microscopy of Mf incubated with M. avium showed
that the associated mycobacteria had been ingested by the
CD431/1 Mf. CD43 was also required for the production
of TNF-a, but not of IL-10, by Mf challenged with M.
avium, strongly suggesting a functional link between the ac-
tion of CD43 in mycobacterial binding and/or uptake and
induction of TNF-a production.
CD43, also called sialophorin or leukosialin, is a preva-
lent sialoglycoprotein on monocytes, neutrophils, and T
lymphocytes (28, 29). On T cells, CD43 extends 45 nm
from the phospholipid bilayer, making it the largest glyco-
protein on the cell surface (30). One function of CD43 is
that of a repulsive or barrier molecule restricting cell to cell
contact (13, 14, 31) due to its negative charge, prevalence,
size, and rigidity. In addition, in vitro binding of CD43
mAb transduces intracellular signals that lead to T lympho-
cyte proliferation (e.g., 32) and activation of macrophages,
increasing homotypic adhesion and hydrogen peroxide
production (32, 33). At the mechanistic level, evidence
suggests that ligation of CD43 induces tyrosine phosphory-
lation reactions (34, 35), and ligated CD43 itself binds the
actin filament linker proteins, moesin and ezrin, which
function in cytoskeletal reorganization (36).
The inability of Mf that lack CD43 to bind mycobacte-
ria and produce TNF-a was corrected by the addition of
Galgp, a purified mucin glycoprotein equivalent to the ex-
tracellular region of CD43. Galgp, which is 76% carbohy-
drate, was originally identified as a plasma component. Its
high content of galactose and N-acetylgalactosamine sug-
gested its identity with the extracellular region of CD43,
and this relationship was confirmed by amino acid sequenc-
ing (18). Isolated plasma Galgp is heterogeneous; all mole-
cules have the NH2-terminal CD43 sequence, but they
have varying COOH termini. The longest species encom-
passes 226 of the 235 extracellular CD43 amino acids. It is
believed that Galgp originates as leukocyte surface CD43
primarily because the single copy (human) CD43 gene en-
codes a single polypeptide that includes a transmembrane
and a cytoplasmic region, missing from Galgp (discussed in
reference 18). Relative to other plasma glycoproteins that
originate as leukocyte surface molecules, the levels of Galgp
are extremely high, .10 mg/ml of normal plasma (37). It is
not known whether Galgp is released by proteolysis from
intact cells or arises by another mechanism, e.g., as a stable
residue remaining after leukocyte death.
Because Galgp was obtained by chromatography (from a
human plasma Cohn fraction), we cannot eliminate the
possibility that the active component that enhances myco-
bacterial adherence is a contaminating species. This sce-
nario is unlikely because contaminants were not seen on
overloaded SDS gels stained for glycoprotein and protein.
Also, trace proteinaceous materials remaining after conven-
tional chromatographic purification were removed by a fi-
nal immunoabsorption step. Importantly, addition of Galgp
to uninfected CD432/2 Mf did not induce TNF-a or IL-
10 (Fig. 7, A–C), indicating that the action of Galgp is not
due to induction of cytokines by trace contaminants.
Two other monomeric mucins, AFGP, which consists of
tandem repeats of an O-glycosylated tripeptide, and PSM-
RT, a derivative of PSM, which consists of tandem repeats
of 81 residues, failed to mediate adherence of M. avium
with Mf (Fig. 6), indicating that the action of Galgp is spe-
cific. Whereas AFGP lacks sialic acid, PSM-RT, like
Galgp, is heavily sialylated, bearing N-glycolylneuraminic
acid on 40–50% of its O-glycans (21). These findings indi-
cate that the effect of Galgp is not simply due to the pres-
ence of sialylated O-glycans.
The finding that Galgp, a soluble species, enables
CD432/2 Mf to bind mycobacteria indicates that CD43
does not by itself function as a surface receptor for myco-
bacteria. Clues to the mode of action of CD43/Galgp might
be found by reference to other functionally interchangeable
membrane protein/soluble protein pairs. These include the
IL-6 receptor (IL-6R), which exists in an integral mem-
brane and a solubilized form elaborated by cleavage from
the cell surface (38). Soluble IL-6R is able to bind IL-6 and
associate with the IL-6R coreceptor gp130, thereby medi-
ating signaling in IL-6R–negative cells (39). Similar behav-
ior is observed for the membrane and soluble forms of
CD14. On binding LPS, soluble CD14, like cell surface
CD14, can trigger intracellular signaling by interacting with
its coreceptor toll-like receptor 2 (TLR-2) (40, 41).
Previous studies have shown that binding and phagocytosis
of mycobacteria by Mf can be mediated by several surface
receptors, including complement receptors CR1, CR3, and
CR4, Fc receptors, CD14, mannose receptor, receptors for
SP-A, and scavenger receptors (for a review, see reference 11).
In light of this plethora of receptors, the near absence of my-
cobacterial uptake in CD432/2 Mf suggests that CD43 func-
tions as a coreceptor or facilitator and/or cofactor of the my-
cobacterial uptake process. The finding that soluble Galgp
restores M. avium binding to CD432/2 Mf but not to CD432
HeLa cells also attests to the contribution of Mf components
other than CD43/Galgp in the interaction with mycobacteria.190 CD43 Is Required for Mycobacterial Binding
The action of Galgp to enhance mycobacteria binding
and/or uptake resembles the action of SP-A. Addition of
SP-A, a member of the collectin (collagen-like lectin) family
of multimeric innate defense glycoproteins, increases the ad-
herence and phagocytosis of M. tuberculosis by Mf (42). Like
Galgp, SP-A must be present during the interaction of myco-
bacteria with Mf. Indeed, reference to earlier studies suggests
a candidate Mf molecule that may functionally interact with
both CD43/Galgp and SP-A. This molecule, a surface glyco-
protein called C1qRp, binds SP-A (43), and the binding of
SP-A to C1qRp enhances the Mf capacity for phagocytosis
of opsonized targets (44). Since it was also shown that CD43
and C1qRp copurify and coimmune precipitate (45), Galgp/
CD43 and C1qRp may be components of a multimeric Mf
complex that enhances mycobacteria binding and uptake.
Inoculation of wild-type Mf with mycobacteria induces
the proinflammatory cytokine TNF-a (46), which is known
to decrease the survival of M. avium (6) by promoting apopto-
sis of the infected host Mf (47), an apparent innate defense
mechanism that prevents systemic spread of infection (8).
M. avium–induced TNF-a production failed to occur in
CD432/2 Mf and was restored by addition of Galgp, strongly
suggesting that the action of CD43 in mycobacterial binding
and/or uptake and TNF-a induction are functionally linked.
On the other hand, M. avium–dependent induction of
IL-10, an antiinflammatory cytokine and TNF-a antago-
nist (27), was not impeded in CD432/2 Mf, strengthening
existing evidence (48) that mycobacteria induce separate or
divergent pathways for TNF-a and IL-10 production.
In summary, this study identifies the surface mucin CD43
as a component essential for robust binding and/or uptake
of mycobacteria by Mf and for mycobacteria-induced
TNF-a production, but not for production of IL-10. Fur-
ther studies are warranted to identify the Mf molecules
that cooperate with CD43 and the mechanism that en-
hances mycobacterial binding.
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